-
Assessing Quality-of-Life Outcomes in Ulcerative Colitis: A Review of Canadian HTA Submissions
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of NALIRIFOX as First-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in Japan
Mar 10, 2025, 14:00 PM -
Methodological Approaches and Current Applications of Distributed Cost-Effectiveness Analysis: A Systematic Review
Mar 10, 2025, 14:00 PM -
Developing a Risk Prediction Model for the Identification of Necrotizing Fasciitis (NF) in Patients
Mar 10, 2025, 14:00 PM -
Parental Self-Efficacy in the Management of Pediatric Type 1 Diabetes Mellitus: A Subgroup Analysis Among CGM Sensor Users
Mar 10, 2025, 14:00 PM -
Time Toxicity of Bispecific Antibody (BsAb) Options in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Fixed-Duration Mosunetuzumab Versus Treat to Progression Epcoritamab
Mar 10, 2025, 14:00 PM -
Willingness to Pay for a Quality Adjusted Life Year Across Different Time Horizons: Direct Elicitation in Quebec
Mar 10, 2025, 14:00 PM -
Receipt of Guideline Concordant Treatment Among Older Adults Newly Diagnosed With Stage III - IV Melanoma Using SEER-Medicare Linked Data
Mar 10, 2025, 14:00 PM -
Temporal Trends in Healthcare Costs Associated with First-Line (1L) Nivolumab + Ipilimumab (N+I) and Pembrolizumab + Lenvatinib (P+L) in Advanced or Metastatic Renal Cell Carcinoma (aRCC)
Mar 10, 2025, 14:00 PM -
Real-World Persistence to Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis in a Commercial and Medicare Advantage Population
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients With Fragile X Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
Information-Seeking Behavior of the Hungarian Population Regarding Lung Cancer: A Digital Epidemiological Study Using Google Trends™
Mar 10, 2025, 14:00 PM -
Tailoring Generalized Cost-Effectiveness Analysis (GCEA) to the U.S. Setting: the Importance of Using the Right Prices
Mar 10, 2025, 14:00 PM -
Hospital Budget Impact Model of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Venetoclax Combination Therapies for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Aged 75 Years or Older, or Who Have Comorbidities That Preclude Use of Intensive Induction Chemotherapy
Mar 10, 2025, 14:00 PM -
The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter
Mar 10, 2025, 14:00 PM -
Antidiabetic Medication Uses Among Pregnant Women: Real-World Prescription Pattern in South Korea
Mar 10, 2025, 14:00 PM -
Do Framing and Attribute Number Influence Choice Consistency in a Preference-Based Value Assessment of Equity and Efficiency?
Mar 10, 2025, 14:00 PM -
Augmenting Small Training Datasets Improves Machine Learning Prognostic Performance
Mar 10, 2025, 14:00 PM
